Absenger, Gudrun
Pircher, Andreas http://orcid.org/0000-0002-7747-3012
Funding for this research was provided by:
University of Innsbruck and Medical University of Innsbruck
Article History
Received: 9 September 2021
Accepted: 4 October 2021
First Online: 18 October 2021
Conflict of interest
: G. Absenger has received honoraria for advisory boards from: AMGEN, AstraZeneca, BMS, Böhringer Ingelheim, Lilly, MSD, Novartis, Pfizer, Roche, Sanofi, Takeda. A. Pircher has received speaker’s fee and honoraria for advisory boards from: Astra Zeneca, BMS, Böhringer Ingelheim, Roche, Pfizer, Takeda and MSD.